Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2020-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,149,540
Percent of class
1.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-014868
Form type
SC 13G
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Jun 12, 2020
Reporting period
Jun 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub